Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024

Silvan Tuerkcan Reiterated (ACRV) at Buy and Held Target at $14 on, Apr 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-14-on-apr-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Silvan Tuerkcan of JMP Securities, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $14 on, Apr 1st, 2024.

Silvan has made no other calls on ACRV in the last 4 months.



There is 1 other peer that has a rating on ACRV. Out of the 1 peers that are also analyzing ACRV, 0 agree with Silvan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Silvan


  • Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024

Publication Contributing Sources